$1.32 Billion is the total value of Opti Capital Management, LP's 37 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DICKS SPORTING GOODS INCnote 3.250% 4/1 | $105,026,000 | -3.5% | 29,655,000 | 0.0% | 7.97% | -22.0% | ||
| Sell | NATERA INCnote 2.250% 5/0 | $96,162,000 | -21.0% | 37,362,000 | -7.9% | 7.29% | -36.2% | |
| New | ZSCALER INCnote 0.125% 7/0 | $90,158,000 | – | 41,140,000 | +100.0% | 6.84% | – | |
| Buy | CONMED CORPnote 2.625% 2/0 | $80,148,000 | +13.1% | 48,065,000 | +5.5% | 6.08% | -8.6% | |
| New | ETSY INCnote 0.125%10/0 | $70,242,000 | – | 27,500,000 | +100.0% | 5.33% | – | |
| Buy | WORKIVA INCnote 1.125% 8/1 | $69,179,000 | +22.8% | 39,038,000 | +30.0% | 5.25% | -0.7% | |
| New | NOVA LTDnote 10/1 | $48,227,000 | – | 24,260,000 | +100.0% | 3.66% | – | |
| SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $45,147,000 | +0.7% | 45,402,000 | 0.0% | 3.42% | -18.6% | ||
| Sell | SAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1 | $44,246,000 | +0.6% | 24,780,000 | -9.2% | 3.36% | -18.6% | |
| New | 8X8 INC NEWnote 0.500% 2/0 | $40,759,000 | – | 40,575,000 | +100.0% | 3.09% | – | |
| VEECO INSTRS INC DELnote 3.750% 6/0 | $40,515,000 | +23.0% | 18,500,000 | 0.0% | 3.07% | -0.6% | ||
| Buy | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $38,379,000 | +7.1% | 42,438,000 | +9.0% | 2.91% | -13.5% | |
| New | ENVESTNET INCnote 1.750% 6/0 | $37,911,000 | – | 30,000,000 | +100.0% | 2.88% | – | |
| Buy | INSIGHT ENTERPRISES INCnote 0.750% 2/1 | $37,486,000 | +28.2% | 23,336,000 | +12.0% | 2.84% | +3.6% | |
| Buy | PEGASYSTEMS INCnote 0.750% 3/0 | $36,583,000 | +180.4% | 34,230,000 | +197.7% | 2.78% | +126.7% | |
| Sell | NEW RELIC INCnote 0.500% 5/0 | $35,998,000 | -46.8% | 30,000,000 | -55.0% | 2.73% | -57.0% | |
| New | AVAYA HLDGS CORPnote 2.250% 6/1 | $32,662,000 | – | 30,695,000 | +100.0% | 2.48% | – | |
| MANDIANT INCnote 1.625% 6/0 | $31,387,000 | 0.0% | 31,309,000 | 0.0% | 2.38% | -19.2% | ||
| KBR INCnote 2.500%11/0 | $30,570,000 | +18.7% | 16,000,000 | 0.0% | 2.32% | -4.0% | ||
| Buy | VONAGE HLDGS CORPnote 1.750% 6/0 | $29,345,000 | +19.7% | 21,880,000 | +4.8% | 2.23% | -3.3% | |
| Buy | RAMBUS INC DELnote 1.375% 2/0 | $28,379,000 | +220.0% | 18,000,000 | +157.1% | 2.15% | +158.7% | |
| Buy | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $27,954,000 | +95.8% | 16,591,000 | +123.7% | 2.12% | +58.2% | |
| REPLIGEN CORPnote 0.375% 7/1 | $24,755,000 | -7.2% | 10,534,000 | 0.0% | 1.88% | -25.0% | ||
| New | ZENDESK INCnote 0.625% 6/1 | $23,962,000 | – | 20,000,000 | +100.0% | 1.82% | – | |
| Sell | FORTIVE CORPnote 0.875% 2/1 | $21,954,000 | -31.6% | 21,927,000 | -31.3% | 1.66% | -44.7% | |
| Sell | ALTERYX INCnote 0.500% 8/0 | $20,875,000 | -31.0% | 22,081,000 | -30.7% | 1.58% | -44.3% | |
| Sell | NUVASIVE INCnote 1.000% 6/0 | $20,135,000 | -12.2% | 19,910,000 | -11.2% | 1.53% | -29.0% | |
| Sell | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $19,670,000 | -39.0% | 17,650,000 | -39.5% | 1.49% | -50.7% | |
| New | HESKA CORPnote 3.750% 9/1 | $14,959,000 | – | 6,616,000 | +100.0% | 1.14% | – | |
| MODEL N INCnote 2.625% 6/0 | $14,057,000 | -7.5% | 12,000,000 | 0.0% | 1.07% | -25.2% | ||
| KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $12,230,000 | +6.9% | 14,960,000 | 0.0% | 0.93% | -13.5% | ||
| Buy | MANDIANT INCnote 0.875% 6/0 | $10,682,000 | +233.9% | 10,216,000 | +240.5% | 0.81% | +170.0% | |
| Buy | LENDINGTREE INCnote 0.500% 7/1 | $9,588,000 | +124.3% | 11,500,000 | +130.0% | 0.73% | +81.3% | |
| Sell | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $8,560,000 | -52.5% | 8,095,000 | -53.6% | 0.65% | -61.6% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $8,505,000 | +1.5% | 8,000,000 | 0.0% | 0.64% | -18.0% | ||
| Buy | VIAVI SOLUTIONS INCnote 1.000% 3/0 | $6,512,000 | +47.1% | 4,596,000 | +35.7% | 0.49% | +19.0% | |
| Sell | OMEROS CORPnote 6.250%11/1 | $5,598,000 | -61.1% | 6,100,000 | -53.8% | 0.42% | -68.5% | |
| Exit | CSG SYS INTL INCnote 4.250% 3/1 | $0 | – | -4,500,000 | -100.0% | -0.44% | – | |
| Exit | IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1 | $0 | – | -5,300,000 | -100.0% | -0.59% | – | |
| Exit | LIGAND PHARMACEUTICALS INCnote 0.750% 5/1 | $0 | – | -8,722,000 | -100.0% | -0.82% | – | |
| Exit | FLEXION THERAPEUTICS INCnote 3.375% 5/0 | $0 | – | -13,158,000 | -100.0% | -1.10% | – | |
| Exit | FIVE9 INCnote 0.500% 6/0 | $0 | – | -17,260,000 | -100.0% | -2.18% | – | |
| Exit | ON SEMICONDUCTOR CORPnote 1.625%10/1 | $0 | – | -25,411,000 | -100.0% | -5.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.